These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36745304)
1. Comprehensive Profiling of Secreted Factors in the Cerebrospinal Fluid of Moyamoya Disease Patients. Abhinav K; Lee AG; Pendharkar AV; Bigder M; Bet A; Rosenberg-Hasson Y; Cheng MY; Steinberg GK Transl Stroke Res; 2024 Apr; 15(2):399-408. PubMed ID: 36745304 [TBL] [Abstract][Full Text] [Related]
2. Different aspects of dysexecutive syndrome in patients with moyamoya disease and its clinical subtypes. Fang L; Huang J; Zhang Q; Chan RC; Wang R; Wan W J Neurosurg; 2016 Aug; 125(2):299-307. PubMed ID: 26722860 [TBL] [Abstract][Full Text] [Related]
3. Multiple Burr-Hole Surgery for the Treatment of Moyamoya Disease and Quasi-Moyamoya Disease in Children: Preliminary Surgical and Imaging Results. Mirone G; Cicala D; Meucci C; d'Amico A; Santoro C; Muto M; Cinalli G World Neurosurg; 2019 Jul; 127():e843-e855. PubMed ID: 30954732 [TBL] [Abstract][Full Text] [Related]
4. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China. Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267 [TBL] [Abstract][Full Text] [Related]
5. Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass. Jiang H; Ni W; Xu B; Lei Y; Tian Y; Xu F; Gu Y; Mao Y J Neurosurg; 2014 Nov; 121(5):1048-55. PubMed ID: 25127415 [TBL] [Abstract][Full Text] [Related]
6. Encephaloduroarteriosynangiosis for hemorrhagic moyamoya disease: long-term outcome of a consecutive series of 95 adult patients from a single center. Wang QN; Bao XY; Zhang Y; Zhang Q; Li DS; Duan L J Neurosurg; 2019 Jun; 130(6):1898-1905. PubMed ID: 29999465 [TBL] [Abstract][Full Text] [Related]
7. Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. Kang HS; Kim JH; Phi JH; Kim YY; Kim JE; Wang KC; Cho BK; Kim SK J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):673-8. PubMed ID: 19965844 [TBL] [Abstract][Full Text] [Related]
8. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults. Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597 [TBL] [Abstract][Full Text] [Related]
9. Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease. Ge P; Zhang Q; Ye X; Liu X; Deng X; Wang R; Zhang Y; Zhang D; Zhao J World Neurosurg; 2017 Apr; 100():459-466. PubMed ID: 28132922 [TBL] [Abstract][Full Text] [Related]
11. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya. Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094 [TBL] [Abstract][Full Text] [Related]
12. Postoperative Functional Outcomes and Prognostic Factors in Two Types of Adult Moyamoya Diseases. Zhang M; Tang J; Liu N; Xue Y; Ren X; Fu J J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104846. PubMed ID: 32439351 [TBL] [Abstract][Full Text] [Related]
13. Flow-augmentation bypass for moyamoya disease. Fujimura M; Tominaga T J Neurosurg Sci; 2021 Jun; 65(3):277-286. PubMed ID: 33245218 [TBL] [Abstract][Full Text] [Related]
14. Association of Brain-Gut Peptides with Inflammatory Cytokines in Moyamoya Disease. Han W; Jin F; Zhang H; Yang M; Cui C; Wang C; Jiang P Mediators Inflamm; 2020; 2020():5847478. PubMed ID: 32410857 [TBL] [Abstract][Full Text] [Related]
15. Significance of Quantitative Cerebral Blood Flow Measurement in the Acute Stage after Revascularization Surgery for Adult Moyamoya Disease: Implication for the Pathological Threshold of Local Cerebral Hyperperfusion. Kameyama M; Fujimura M; Tashiro R; Sato K; Endo H; Niizuma K; Mugikura S; Tominaga T Cerebrovasc Dis; 2019; 48(3-6):217-225. PubMed ID: 31812964 [TBL] [Abstract][Full Text] [Related]
16. Topographic changes in cerebral blood flow and reduced white matter integrity in the first 2 weeks following revascularization surgery in adult moyamoya disease. Kazumata K; Tha KK; Uchino H; Shiga T; Shichinohe H; Ito M; Nakayama N; Abumiya T J Neurosurg; 2017 Aug; 127(2):260-269. PubMed ID: 27588593 [TBL] [Abstract][Full Text] [Related]
17. A Vessel Wall MRI Investigation in Patients With Moyamoya or Quasi-Moyamoya Disease: Diagnosis, Features, and Outcomes. Yu LB; Shen M; Zhang Q; Zhang D J Craniofac Surg; 2024 Jan-Feb 01; 35(1):e24-e28. PubMed ID: 37622552 [TBL] [Abstract][Full Text] [Related]
18. Hemorrhagic Moyamoya Disease : A Recent Update. Fujimura M; Tominaga T J Korean Neurosurg Soc; 2019 Mar; 62(2):136-143. PubMed ID: 30428637 [TBL] [Abstract][Full Text] [Related]